Showing 461 - 480 results of 2,482 for search '"hepatitis"', query time: 0.05s Refine Results
  1. 461
  2. 462
  3. 463
  4. 464

    Treatment-Resistant Hepatitis C Viral Infection: A Case Report and Literature Review by Victoria Green, Marina Roytman

    Published 2022-01-01
    “…Hepatitis C virus (HCV) is an ongoing global public health threat affecting millions worldwide. …”
    Get full text
    Article
  5. 465
  6. 466
  7. 467
  8. 468
  9. 469

    The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients by Lingjuan Ruan, Lifei Huang, Lilai Zhao, Qiang Wang, Xiaocheng Pan, Anmin Zhang, Qiuping Bai, Zongjun Lv

    Published 2018-01-01
    “…Hepatitis B virus (HBV) infection is a major risk factor for the development of hepatic cirrhosis (HC) and hepatocellular carcinoma (HCC), which are associated with very high morbidity and mortality rates worldwide. …”
    Get full text
    Article
  10. 470
  11. 471
  12. 472

    Pyoderma Gangrenosum and Autoimmune Chronic Active Hepatitis in a 17-Year-Old Female by Joanne M. Langley, Eve A. Roberts, Moshe Ipp, Ronald M. Laxer, Lionel Boxall, M. James Phillips

    Published 1988-01-01
    “…Autoimmune chronic active hepatitis and pyoderma gangrenosum are a rare association and this is the youngest patient in whom the association has been reported.…”
    Get full text
    Article
  13. 473

    Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis by Daniela Cabibi, Fabrizio Bronte, Rossana Porcasi, Sabrina Ingrao, Antonino Giulio Giannone, Marcello Maida, Maria Grazia Bavetta, Salvatore Petta, Vito Di Marco, Vincenza Calvaruso

    Published 2015-01-01
    “…The best staining to evaluate liver fibrosis in liver hepatitis is still a debated topic. This study aimed to compare Masson’s trichrome (MT), Sirius Red (SR), and orcein stainings in evaluating liver fibrosis in chronic HCV hepatitis (CHC) with semiquantitative and quantitative methods (Collagen Proportionate Area (CPA) by Digital Image Analysis (DIA)) and correlate them with transient elastography (TE). …”
    Get full text
    Article
  14. 474
  15. 475

    Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians by Curtis L Cooper, Robert J Bailey, Vince G Bain, Frank Anderson, Eric M Yoshida, Mel Krajden, Paul Marotta, for the Canadian Pegasys Study Group

    Published 2008-01-01
    “…BACKGROUND: There is little published information on baseline characteristics and therapeutic outcomes in hepatitis C virus (HCV)-infected Aboriginal Canadians. …”
    Get full text
    Article
  16. 476
  17. 477

    Estimation of the Secondary Attack Rate for Delta Hepatitis Coinfection among Injection Drug Users by Christiane Poulin, Theresa Gyorkos, Lawrence Joseph

    Published 1993-01-01
    “…Six IDUs formed a cluster of delta hepatitis coinfections, representing the first reported outbreak of delta hepatitis in Canada. …”
    Get full text
    Article
  18. 478

    Prevalence of Hepatic Encephalopathy from a Commercial Medical Claims Database in the United States by Aniruddha Potnis, Susan VanMeter, Jan Stange

    Published 2021-01-01
    “…Introduction. Hepatic encephalopathy (HE), a complication of cirrhosis, is associated with increased healthcare resource utilization and mortality, and impaired quality of life. …”
    Get full text
    Article
  19. 479
  20. 480